D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia

Hiroyuki Uchida, Tarek K. Rajji, Benoit H. Mulsant, Shitij Kapur, Bruce G. Pollock, Ariel Graff-Guerrero, Mahesh Menon, David C. Mamo

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The negative impact of antipsychotic drugs on attention is expected to be greater in late-life schizophrenia because of the age-related changes in the dopamine receptor reserve. The objective of this study was to examine the relationship between dopamine D2 receptor blockade by risperidone and the cognitive function in late-life schizophrenia. Subjects with schizophrenia or schizoaffective disorder aged 50 or older who were receiving risperidone completed a [C]raclopride positron emission tomography scan to measure D2-binding potential in the striatum. The D2 receptor blockade by risperidone was calculated using age-corrected measures from healthy individuals and region of interest analysis of dynamic positron emission tomography data coregistered to the subjects' magnetic resonance imaging scans. Cognitive function was assessed using a battery of neuropsychological tests that included the Dementia Rating Scale-2 (DRS). Eleven subjects (mean ± SD age, 64 ± 8 years) participated in this study. The mean ± SD D2 receptor blockade was 69% ± 14% (range, 34%-80%). The age-corrected score on the attention subscale in the DRS was negatively correlated with the D2 receptor blockade. The DRS attention subscale score was lower in the subjects who experienced 74.9% or higher D2 blockade (median value, corresponding to a daily risperidone dose of >3.0 mg) than in those who did not. Although a causal attribution cannot be made in light of the cross-sectional nature of this study, the results suggest the critical importance of identifying the lowest effective dose of antipsychotic drugs in older patients with schizophrenia.

Original languageEnglish
Pages (from-to)571-575
Number of pages5
JournalJournal of clinical psychopharmacology
Volume29
Issue number6
DOIs
Publication statusPublished - 2009 Dec 1
Externally publishedYes

Keywords

  • Cognitive function
  • Dopamine
  • Elderly
  • PET
  • Risperidone
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia'. Together they form a unique fingerprint.

  • Cite this

    Uchida, H., Rajji, T. K., Mulsant, B. H., Kapur, S., Pollock, B. G., Graff-Guerrero, A., Menon, M., & Mamo, D. C. (2009). D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia. Journal of clinical psychopharmacology, 29(6), 571-575. https://doi.org/10.1097/JCP.0b013e3181bf4ea3